-+ 0.00%
-+ 0.00%
-+ 0.00%

Avalon Pharma Renews SAR104 Million Bank Facility Deal with Banque Saudi Fransi

MT Newswires·09/17/2026 10:00:49
语音播报
10:00 AM EDT, 09/17/2026 (MT Newswires) -- Middle East Pharmaceutical Industries Co (SASE:4016), d/b/a Avalon Pharma, renewed its one-year bank facility agreement amounting to 104 million Saudi riyals with Banque Saudi Fransi. The Tadawul-listed pharmaceutical company said Thursday the Sharia-compliant facility will be used to fund its working capital.